Nearly 30 drug makers will raise the prices of their medicines in January after a temporary halt to increases; more than 180,000 Virginians without insurance coverage will now have access to Medicaid coverage under the program’s expansion; despite lagging far behind 2017's enrollment numbers for most of open enrollment, the number of people who signed up for Affordable Care Act plans on HealthCare.gov was only down 4% after a surge of sign-ups last week.
Nearly 30 drug makers will raise the prices of their medicines in January after a temporary halt to increases. Reuters reported that some of the companies expected to increase prices were Allergan Plc, GlaxoSmithKline Plc, Amgen Inc, and Novartis AG. After criticisms from President Donald Trump, many drug makers had decided to pause drug price hikes. In California, where a new state law requires companies notify payers if they intend double-digit percentage increases over 2 years, 28 drug makers filed notifications for price increases.
More than 180,000 Virginians without insurance coverage will now have Medicaid coverage under the program’s expansion. The state General Assembly expanded Medicaid to cover people earning up to 138% of the federal poverty line, which made an additional 400,000 people eligible for Medicaid, according to the Richmond Times-Dispatch. Virginia’s Department of Medical Assistance Services expects 360,000 people to have enrolled by the end of 2019.
Throughout open enrollment, the number of people signing up for Affordable Care Act plans on HealthCare.gov had lagged behind 2017. However, after a surge of sign-ups in the last week, enrollment is now only down 4% compared with the same point last year, reported The New York Times. In the last week of enrollment, 4.3 million people signed up, which surpassed the 4.1 million who signed up in the last week of 2017. CMS Administrator Seema Verma suggested that the low unemployment rate may have contributed to the drop since more Americans likely have employer-based coverage. The number of sign-ups increased in 5 states: Florida, Hawaii, Mississippi, Oklahoma, and Wyoming.
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Early Involvement Critical in Treating Immunotherapy-Induced Overlap Syndrome
April 19th 2024A series of case studies reveals the importance of early diagnosis and involvement of special teams of clinicians when dealing with potential cases of overlap syndrome, which encompasses myocarditis, myasthenia gravis, and immune checkpoint inhibitor–related myositis.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen